MeiraGTx Holdings (MGTX) Cash from Operations Growth (1y) (2018 - 2025)
MeiraGTx Holdings (MGTX) Cash from Operations Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 158.60% |
| 10 | MeiraGTx Holdings | 994.52 Mn | 928.59 Mn | - | 300.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 300.34% |
| Sep 30, 2025 | 51.18% |
| Jun 30, 2025 | -126.02% |
| Mar 31, 2025 | -0.16% |
| Dec 31, 2024 | -60.01% |
| Sep 30, 2024 | -2.49% |
| Jun 30, 2024 | 32.94% |
| Mar 31, 2024 | 1.74% |
| Dec 31, 2023 | 10.57% |
| Sep 30, 2023 | -17.79% |
| Jun 30, 2023 | -4.33% |
| Mar 31, 2023 | -350.61% |
| Dec 31, 2022 | -186.40% |
| Sep 30, 2022 | -20.62% |
| Jun 30, 2022 | -30.79% |
| Mar 31, 2022 | -191.33% |
| Dec 31, 2021 | 163.69% |
| Sep 30, 2021 | -87.98% |
| Jun 30, 2021 | -65.07% |
| Mar 31, 2021 | 173.37% |